Publications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (10)

2024

  1. Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 6, pp. 411-419

  2. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 575-586

  3. Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study

    Diabetes Research and Clinical Practice, Vol. 207

  4. Current barriers to initiating insulin therapy in individuals with type 2 diabetes

    Frontiers in Endocrinology, Vol. 15

2023

  1. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  2. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

    Diabetes Therapy, Vol. 14, Núm. 4, pp. 723-736

2022

  1. Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

  2. Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience

    Diabetes care, Vol. 45, Núm. 3, pp. 650-658

  3. The Controversial Role of Vitamin D in Thyroid Cancer Prevention

    Nutrients, Vol. 14, Núm. 13

2020

  1. Biosimilars and Novel Insulins

    American Journal of Therapeutics, Vol. 27, Núm. 1, pp. E52-E61